Stem Cell Center
591 – 600 of 802
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
High Resolution Screening of Copy-Number Alterations in Chronic Lymphocytic Leukemia Using Affymetrix 250K SNP-Arrays Reveals a Higher Complexity of Genomic Alterations in Patients with Unmutated IGHV Genes
(
- Contribution to journal › Published meeting abstract
-
Mark
Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Transendothelial migration capacity of human culture-derived mesenchymal stromal cells and primary CD271+bone marrow cells
(
- Contribution to journal › Published meeting abstract
-
Mark
Cystatin C and cathepsins in cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
MaFA is a dedicated activator of the insulin gene in vivo.
(
- Contribution to journal › Article
-
Mark
Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion.
(
- Contribution to journal › Article
-
Mark
Exit of pediatric pre-B acute lymphoblastic leukaemia cells from the bone marrow to the peripheral blood is not associated with cell maturation or alterations in gene expression.
(
- Contribution to journal › Article
-
Mark
The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils.
(
- Contribution to journal › Article
-
Mark
Definitive endoderm: a key step in coaxing human embryonic stem cells into transplantable beta-cells.
(
- Contribution to journal › Article
-
Mark
Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1.
(
- Contribution to journal › Article